| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Cytos Biotechnology AG, Schlieren-Zürich, Switzerland; and
Paul Scherrer Institut, Villigen, Switzerland
DNA rich in nonmethylated CG motifs (CpGs) greatly facilitates induction of immune responses against coadministered Ags. CpGs are therefore among the most promising adjuvants known to date. Nevertheless, CpGs are characterized by two drawbacks. They have unfavorable pharmacokinetics and may exhibit systemic side effects, including splenomegaly. We show in this study that packaging CpGs into virus-like particles (VLPs) derived from the hepatitis B core Ag or the bacteriophage Q
is a simple and attractive method to reduce these two problems. CpGs packaged into VLPs are resistant to DNase I digestion, enhancing their stability. In addition, and in contrast to free CpGs, packaging CpGs prevents splenomegaly in mice, without affecting their immunostimulatory capacity. In fact, vaccination with CpG-loaded VLPs was able to induce high frequencies of peptide-specific CD8+ T cells (4–14%), protected from infection with recombinant vaccinia viruses, and eradicated established solid fibrosarcoma tumors. Thus, packaging CpGs into VLPs improves both their immunogenicity and pharmacodynamics.
This article has been cited by other articles:
|
|
 |
|
  B. O. Lee, A. Tucker, L. Frelin, M. Sallberg, J. Jones, C. Peters, J. Hughes, D. Whitacre, B. Darsow, D. L. Peterson, et al. Interaction of the Hepatitis B Core Antigen and the Innate Immune System J. Immunol., June 1, 2009; 182(11): 6670 - 6681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chackerian, M. R. Durfee, and J. T. Schiller Virus-Like Display of a Neo-Self Antigen Reverses B Cell Anergy in a B Cell Receptor Transgenic Mouse Model J. Immunol., May 1, 2008; 180(9): 5816 - 5825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Anderson, G. J. Cianciolo, M. N. Kennedy, and S. V. Pizzo {alpha}2-Macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism J. Leukoc. Biol., February 1, 2008; 83(2): 381 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Agnellini, M. Wiesel, K. Schwarz, P. Wolint, M. F. Bachmann, and A. Oxenius Kinetic and Mechanistic Requirements for Helping CD8 T Cells J. Immunol., February 1, 2008; 180(3): 1517 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lacasse, J. Denis, R. Lapointe, D. Leclerc, and A. Lamarre Novel Plant Virus-Based Vaccine Induces Protective Cytotoxic T-Lymphocyte-Mediated Antiviral Immunity through Dendritic Cell Maturation J. Virol., January 15, 2008; 82(2): 785 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jegerlehner, P. Maurer, J. Bessa, H. J. Hinton, M. Kopf, and M. F. Bachmann TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a J. Immunol., February 15, 2007; 178(4): 2415 - 2420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. S. Liu, J. Dyer, G. R. Leggatt, G. J. P. Fernando, J. Zhong, R. Thomas, and I. H. Frazer Overcoming Original Antigenic Sin to Generate New CD8 T Cell IFN-{gamma} Responses in an Antigen-Experienced Host. J. Immunol., September 1, 2006; 177(5): 2873 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Pawar, P. S. Patole, M. Wornle, and H.-J. Anders Microbial nucleic acids pay a Toll in kidney disease Am J Physiol Renal Physiol, September 1, 2006; 291(3): F509 - F516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cooper and Y. Shaul Clathrin-mediated Endocytosis and Lysosomal Cleavage of Hepatitis B Virus Capsid-like Core Particles J. Biol. Chem., June 16, 2006; 281(24): 16563 - 16569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Bachmann, P. Wolint, K. Schwarz, and A. Oxenius Recall Proliferation Potential of Memory CD8+ T Cells and Antiviral Protection J. Immunol., October 1, 2005; 175(7): 4677 - 4685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Bachmann, P. Wolint, K. Schwarz, P. Jager, and A. Oxenius Functional Properties and Lineage Relationship of CD8+ T Cell Subsets Identified by Expression of IL-7 Receptor {alpha} and CD62L J. Immunol., October 1, 2005; 175(7): 4686 - 4696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ruedl, K. Schwarz, A. Jegerlehner, T. Storni, V. Manolova, and M. F. Bachmann Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies J. Virol., January 15, 2005; 79(2): 717 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vanlandschoot, F. Van Houtte, B. Serruys, and G. Leroux-Roels The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate J. Gen. Virol., January 1, 2005; 86(1): 75 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Bachmann, K. Schwarz, P. Wolint, E. Meijerink, S. Martin, V. Manolova, and A. Oxenius Cutting Edge: Distinct Roles for T Help and CD40/CD40 Ligand in Regulating Differentiation of Proliferation-Competent Memory CD8+ T Cells J. Immunol., August 15, 2004; 173(4): 2217 - 2221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Storni and M. F. Bachmann Loading of MHC Class I and II Presentation Pathways by Exogenous Antigens: A Quantitative In Vivo Comparison J. Immunol., May 15, 2004; 172(10): 6129 - 6135. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
